Douglas S. Krakower, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anti-HIV Agents | 62 | 2024 | 4559 | 6.110 |
Why?
|
HIV Infections | 102 | 2024 | 17533 | 5.810 |
Why?
|
Homosexuality, Male | 32 | 2024 | 1342 | 3.930 |
Why?
|
Chemoprevention | 6 | 2018 | 327 | 1.530 |
Why?
|
Health Personnel | 17 | 2024 | 3390 | 1.350 |
Why?
|
Acquired Immunodeficiency Syndrome | 6 | 2024 | 2203 | 1.290 |
Why?
|
Post-Exposure Prophylaxis | 7 | 2024 | 113 | 1.200 |
Why?
|
Health Knowledge, Attitudes, Practice | 24 | 2024 | 4058 | 1.140 |
Why?
|
Alanine | 3 | 2024 | 612 | 1.050 |
Why?
|
Adenine | 5 | 2024 | 994 | 1.030 |
Why?
|
Infectious Disease Medicine | 3 | 2020 | 51 | 1.000 |
Why?
|
Syphilis | 3 | 2023 | 243 | 0.980 |
Why?
|
Anti-Retroviral Agents | 8 | 2024 | 1787 | 0.950 |
Why?
|
Prescription Drugs | 2 | 2022 | 634 | 0.950 |
Why?
|
Heterosexuality | 5 | 2020 | 308 | 0.940 |
Why?
|
Patient Acceptance of Health Care | 12 | 2024 | 3230 | 0.880 |
Why?
|
Focus Groups | 6 | 2024 | 1459 | 0.870 |
Why?
|
Sexual Behavior | 14 | 2024 | 2193 | 0.850 |
Why?
|
Disease Transmission, Infectious | 4 | 2018 | 560 | 0.840 |
Why?
|
Nonprescription Drugs | 1 | 2023 | 119 | 0.790 |
Why?
|
Risk-Taking | 8 | 2019 | 1021 | 0.740 |
Why?
|
Sexually Transmitted Diseases, Bacterial | 2 | 2024 | 31 | 0.720 |
Why?
|
Primary Health Care | 11 | 2021 | 4736 | 0.700 |
Why?
|
Anus Neoplasms | 1 | 2024 | 336 | 0.700 |
Why?
|
Attitude of Health Personnel | 9 | 2024 | 3925 | 0.670 |
Why?
|
Health Services Accessibility | 8 | 2023 | 5508 | 0.670 |
Why?
|
Condoms | 9 | 2020 | 336 | 0.610 |
Why?
|
Sexual Partners | 11 | 2024 | 804 | 0.590 |
Why?
|
Qualitative Research | 11 | 2024 | 3139 | 0.590 |
Why?
|
Decision Support Systems, Clinical | 2 | 2024 | 1175 | 0.570 |
Why?
|
Health Services Administration | 1 | 2018 | 63 | 0.560 |
Why?
|
Drug Costs | 2 | 2022 | 1193 | 0.560 |
Why?
|
Interviews as Topic | 10 | 2024 | 2739 | 0.530 |
Why?
|
Epidemics | 2 | 2020 | 514 | 0.460 |
Why?
|
Drug Resistance, Viral | 2 | 2019 | 866 | 0.460 |
Why?
|
Humans | 112 | 2024 | 765968 | 0.450 |
Why?
|
Hepatitis C | 3 | 2019 | 1597 | 0.450 |
Why?
|
Substance Abuse, Intravenous | 3 | 2023 | 531 | 0.430 |
Why?
|
Intention | 5 | 2020 | 346 | 0.420 |
Why?
|
Male | 71 | 2024 | 363698 | 0.410 |
Why?
|
Papillomavirus Infections | 1 | 2024 | 1640 | 0.400 |
Why?
|
Electronic Health Records | 6 | 2024 | 4873 | 0.370 |
Why?
|
HIV | 5 | 2023 | 1585 | 0.370 |
Why?
|
Drug Users | 2 | 2023 | 134 | 0.370 |
Why?
|
Community Health Centers | 4 | 2020 | 469 | 0.360 |
Why?
|
Social Stigma | 5 | 2023 | 788 | 0.350 |
Why?
|
Health Services Research | 1 | 2018 | 1808 | 0.340 |
Why?
|
Early Detection of Cancer | 1 | 2024 | 3236 | 0.340 |
Why?
|
Adult | 46 | 2024 | 223044 | 0.330 |
Why?
|
Perception | 6 | 2020 | 1205 | 0.320 |
Why?
|
Drug Prescriptions | 5 | 2019 | 1662 | 0.320 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2011 | 618 | 0.300 |
Why?
|
Continuity of Patient Care | 1 | 2015 | 1078 | 0.300 |
Why?
|
Physicians | 6 | 2017 | 4588 | 0.290 |
Why?
|
Education, Medical, Continuing | 2 | 2023 | 830 | 0.280 |
Why?
|
Medication Adherence | 5 | 2023 | 2192 | 0.270 |
Why?
|
Costs and Cost Analysis | 2 | 2022 | 1668 | 0.270 |
Why?
|
Unsafe Sex | 3 | 2017 | 239 | 0.260 |
Why?
|
Motivation | 3 | 2022 | 2018 | 0.260 |
Why?
|
Communicable Disease Control | 1 | 2012 | 856 | 0.260 |
Why?
|
Internet | 7 | 2016 | 3106 | 0.250 |
Why?
|
Boston | 6 | 2019 | 9338 | 0.250 |
Why?
|
Middle Aged | 32 | 2024 | 223009 | 0.240 |
Why?
|
Sindbis Virus | 2 | 2001 | 36 | 0.230 |
Why?
|
Bird Diseases | 2 | 2001 | 20 | 0.230 |
Why?
|
Condylomata Acuminata | 1 | 2024 | 79 | 0.230 |
Why?
|
Risk Reduction Behavior | 3 | 2020 | 1123 | 0.230 |
Why?
|
Alphavirus Infections | 2 | 2001 | 20 | 0.230 |
Why?
|
Female | 45 | 2024 | 396112 | 0.230 |
Why?
|
Medical Informatics | 1 | 2010 | 745 | 0.210 |
Why?
|
Safe Sex | 3 | 2019 | 144 | 0.210 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 7478 | 0.210 |
Why?
|
Sexually Transmitted Diseases | 3 | 2024 | 667 | 0.200 |
Why?
|
Doxycycline | 1 | 2024 | 349 | 0.200 |
Why?
|
Orgasm | 1 | 2021 | 63 | 0.190 |
Why?
|
Health Communication | 2 | 2022 | 216 | 0.190 |
Why?
|
United States | 24 | 2024 | 72903 | 0.190 |
Why?
|
Stereotyping | 3 | 2019 | 242 | 0.180 |
Why?
|
Bisexuality | 3 | 2024 | 295 | 0.180 |
Why?
|
Disease Vectors | 1 | 2001 | 61 | 0.180 |
Why?
|
Needle-Exchange Programs | 1 | 2021 | 28 | 0.180 |
Why?
|
Mass Screening | 3 | 2024 | 5446 | 0.180 |
Why?
|
Anti-Infective Agents, Local | 2 | 2013 | 245 | 0.170 |
Why?
|
Africa, Eastern | 1 | 2020 | 76 | 0.170 |
Why?
|
Birds | 1 | 2001 | 165 | 0.170 |
Why?
|
Prisoners | 1 | 2023 | 316 | 0.170 |
Why?
|
Teaching Rounds | 1 | 2024 | 280 | 0.160 |
Why?
|
Algorithms | 2 | 2019 | 14071 | 0.160 |
Why?
|
Self-Help Groups | 1 | 2020 | 193 | 0.160 |
Why?
|
Young Adult | 16 | 2024 | 59889 | 0.150 |
Why?
|
Prejudice | 3 | 2019 | 567 | 0.150 |
Why?
|
Decision Making | 2 | 2024 | 3965 | 0.150 |
Why?
|
Career Mobility | 1 | 2020 | 259 | 0.150 |
Why?
|
Kenya | 1 | 2020 | 758 | 0.150 |
Why?
|
Practice Guidelines as Topic | 4 | 2019 | 7425 | 0.130 |
Why?
|
New England | 2 | 2019 | 1059 | 0.130 |
Why?
|
Primary Prevention | 2 | 2015 | 1187 | 0.130 |
Why?
|
Cross-Sectional Studies | 8 | 2021 | 26318 | 0.130 |
Why?
|
Uganda | 1 | 2020 | 1353 | 0.130 |
Why?
|
Diagnostic Tests, Routine | 2 | 2017 | 790 | 0.120 |
Why?
|
Physicians, Primary Care | 3 | 2017 | 622 | 0.120 |
Why?
|
Students, Medical | 2 | 2018 | 1959 | 0.120 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2780 | 0.110 |
Why?
|
Trust | 1 | 2019 | 533 | 0.110 |
Why?
|
Alabama | 2 | 2024 | 111 | 0.110 |
Why?
|
Preventive Health Services | 1 | 2017 | 570 | 0.100 |
Why?
|
Healthcare Disparities | 2 | 2019 | 3413 | 0.100 |
Why?
|
Mycobacterium marinum | 1 | 2012 | 29 | 0.100 |
Why?
|
Multivariate Analysis | 5 | 2019 | 12056 | 0.100 |
Why?
|
Public Opinion | 1 | 2016 | 482 | 0.100 |
Why?
|
Specialization | 1 | 2017 | 777 | 0.100 |
Why?
|
Hepatitis B | 1 | 2017 | 707 | 0.100 |
Why?
|
Faculty, Medical | 1 | 2020 | 1219 | 0.100 |
Why?
|
Homosexuality | 1 | 2012 | 267 | 0.100 |
Why?
|
Skin Diseases, Bacterial | 1 | 2012 | 68 | 0.100 |
Why?
|
Counseling | 1 | 2019 | 1551 | 0.090 |
Why?
|
Culture | 1 | 2015 | 622 | 0.090 |
Why?
|
Directive Counseling | 1 | 2012 | 171 | 0.090 |
Why?
|
Gels | 1 | 2011 | 419 | 0.090 |
Why?
|
Antibodies, Viral | 2 | 2001 | 3211 | 0.090 |
Why?
|
Massachusetts | 3 | 2019 | 8875 | 0.090 |
Why?
|
Herpesvirus 3, Human | 1 | 2011 | 159 | 0.090 |
Why?
|
Adolescent | 9 | 2024 | 88835 | 0.080 |
Why?
|
Canada | 1 | 2015 | 2119 | 0.080 |
Why?
|
Opportunistic Infections | 1 | 2012 | 376 | 0.080 |
Why?
|
Professional Competence | 1 | 2012 | 429 | 0.080 |
Why?
|
Communication | 2 | 2024 | 3916 | 0.080 |
Why?
|
Crohn Disease | 2 | 2012 | 2283 | 0.080 |
Why?
|
Immunosuppressive Agents | 2 | 2012 | 4209 | 0.080 |
Why?
|
Physician-Patient Relations | 2 | 2019 | 3278 | 0.080 |
Why?
|
Herpes Zoster | 1 | 2011 | 252 | 0.080 |
Why?
|
Drug Combinations | 1 | 2015 | 2077 | 0.080 |
Why?
|
Deoxycytidine | 1 | 2012 | 889 | 0.070 |
Why?
|
Health Behavior | 1 | 2018 | 2650 | 0.070 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2009 | 265 | 0.070 |
Why?
|
Immunocompromised Host | 1 | 2012 | 866 | 0.070 |
Why?
|
Risk Factors | 7 | 2024 | 74840 | 0.070 |
Why?
|
Health Services Needs and Demand | 1 | 2014 | 1406 | 0.070 |
Why?
|
HIV-1 | 2 | 2021 | 6944 | 0.070 |
Why?
|
Logistic Models | 3 | 2016 | 13266 | 0.060 |
Why?
|
Public Health | 1 | 2019 | 2680 | 0.060 |
Why?
|
Secondary Prevention | 1 | 2012 | 1472 | 0.060 |
Why?
|
Socioeconomic Factors | 5 | 2018 | 7838 | 0.060 |
Why?
|
Health Surveys | 1 | 2015 | 4056 | 0.060 |
Why?
|
Antiviral Agents | 2 | 2013 | 3050 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3105 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 10383 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14751 | 0.050 |
Why?
|
Sex Factors | 3 | 2022 | 10603 | 0.050 |
Why?
|
Chlamydia trachomatis | 1 | 2023 | 240 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8703 | 0.050 |
Why?
|
Prescriptions | 1 | 2024 | 388 | 0.050 |
Why?
|
Songbirds | 1 | 2001 | 23 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 4348 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3685 | 0.040 |
Why?
|
Cultural Competency | 1 | 2023 | 303 | 0.040 |
Why?
|
Philosophy | 1 | 2020 | 70 | 0.040 |
Why?
|
Odds Ratio | 1 | 2012 | 9649 | 0.040 |
Why?
|
Needle Sharing | 1 | 2019 | 22 | 0.040 |
Why?
|
Judgment | 1 | 2021 | 270 | 0.040 |
Why?
|
Professional-Patient Relations | 1 | 2024 | 721 | 0.040 |
Why?
|
Aged | 4 | 2024 | 171117 | 0.040 |
Why?
|
Ohio | 1 | 2020 | 320 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 1 | 2024 | 644 | 0.040 |
Why?
|
Neutralization Tests | 1 | 2001 | 735 | 0.040 |
Why?
|
Achievement | 1 | 2020 | 287 | 0.040 |
Why?
|
Income | 2 | 2017 | 1874 | 0.040 |
Why?
|
Prospective Studies | 2 | 2023 | 54802 | 0.040 |
Why?
|
Philadelphia | 1 | 2019 | 267 | 0.040 |
Why?
|
Choice Behavior | 1 | 2024 | 844 | 0.040 |
Why?
|
Psychological Theory | 1 | 2019 | 172 | 0.040 |
Why?
|
Prevalence | 3 | 2019 | 15842 | 0.040 |
Why?
|
Sweden | 1 | 2001 | 1381 | 0.040 |
Why?
|
New York City | 1 | 2019 | 733 | 0.030 |
Why?
|
Minority Groups | 1 | 2023 | 1207 | 0.030 |
Why?
|
Self Efficacy | 1 | 2020 | 642 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2020 | 65188 | 0.030 |
Why?
|
Poverty | 2 | 2017 | 2714 | 0.030 |
Why?
|
Serologic Tests | 1 | 2017 | 382 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2012 | 9249 | 0.030 |
Why?
|
Preventive Medicine | 1 | 2016 | 246 | 0.030 |
Why?
|
Patient Care | 1 | 2019 | 629 | 0.030 |
Why?
|
Antigens, Viral | 1 | 2017 | 995 | 0.030 |
Why?
|
New York | 1 | 2015 | 880 | 0.030 |
Why?
|
Tobacco Use Disorder | 1 | 2018 | 708 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4850 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2018 | 939 | 0.020 |
Why?
|
Administration, Oral | 1 | 2020 | 4015 | 0.020 |
Why?
|
Polyradiculopathy | 1 | 2011 | 23 | 0.020 |
Why?
|
World Health Organization | 1 | 2017 | 1328 | 0.020 |
Why?
|
Animals | 3 | 2019 | 168764 | 0.020 |
Why?
|
Meningitis, Viral | 1 | 2011 | 49 | 0.020 |
Why?
|
Risk Assessment | 1 | 2012 | 24282 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15880 | 0.020 |
Why?
|
Data Collection | 1 | 2020 | 3318 | 0.020 |
Why?
|
California | 1 | 2015 | 1436 | 0.020 |
Why?
|
Influenza Vaccines | 1 | 2018 | 778 | 0.020 |
Why?
|
Health Education | 1 | 2017 | 1060 | 0.020 |
Why?
|
Hepacivirus | 1 | 2017 | 1343 | 0.020 |
Why?
|
Acyclovir | 1 | 2011 | 267 | 0.020 |
Why?
|
Seasons | 1 | 2016 | 1524 | 0.020 |
Why?
|
Medicaid | 1 | 2023 | 2833 | 0.020 |
Why?
|
Testosterone | 1 | 2001 | 2494 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2017 | 2424 | 0.020 |
Why?
|
RNA, Viral | 1 | 2017 | 2864 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2019 | 2116 | 0.020 |
Why?
|
Educational Status | 1 | 2016 | 2513 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1458 | 0.020 |
Why?
|
Urban Population | 1 | 2014 | 2040 | 0.020 |
Why?
|
Cognition | 1 | 2024 | 7049 | 0.020 |
Why?
|
Age Factors | 2 | 2016 | 18380 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 21480 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2009 | 1602 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5526 | 0.010 |
Why?
|
Body Mass Index | 1 | 2022 | 13039 | 0.010 |
Why?
|
Diarrhea | 1 | 2009 | 1316 | 0.010 |
Why?
|
Nursing Homes | 1 | 2009 | 1084 | 0.010 |
Why?
|
Immunocompetence | 1 | 2001 | 138 | 0.010 |
Why?
|
Risk | 1 | 2012 | 9591 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2018 | 5891 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 13076 | 0.010 |
Why?
|
Depression | 1 | 2018 | 8237 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20124 | 0.010 |
Why?
|
Viremia | 1 | 2001 | 727 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 8041 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 40065 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41649 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 81514 | 0.010 |
Why?
|
Hospitalization | 1 | 2009 | 10808 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2009 | 59489 | 0.000 |
Why?
|